Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Suspended × Sarcoma × Clear all

Phase

Phase 1 5 Phase 2 4 Phase NA 1 Phase 1/2 1

Status

Completed 141 Recruiting 73 Unknown 49 Terminated 36 Active not recruiting 22 Withdrawn 14 Not yet recruiting 13 Enrolling by invitation 2 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 13 Gastrointestinal 10 Breast 9 Genitourinary 8 Head & Neck 6 Lymphoid 5 Tumor-Agnostic 3 Other solid neoplasm 3 Plasma cell 2 Other hematologic neoplasm 2 Other 2 Gynecologic 2 Dermatologic 2 Thoracic 1 Sarcoma 1 Other neoplasm 1 Myeloid 1

Conditions

Gastrointestinal Stromal Tumors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02924714 2022-02-18

SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST

Oslo University Hospital

Phase NA Suspended

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡